Breathomix is a Dutch SME founded in June 2018 with the ambition to transform the way patients with respiratory diseases such as asthma, COPD and lung cancer are diagnosed and managed by bringing the innovative BreathBase Solution to point-of-care. During the past 15 years, Peter Sterk’s group at the Amsterdam University Medical Centres has developed and successfully validated exhaled breath technologies for the molecular classification of patients with cancer, inflammatory and infectious diseases. With a background in technical medicine and a specialization in signal analysis, Rianne de Vries developed the proprietary analysis software of the BreathBase Platform which is linked to the SpiroNose. Breathomix consists of a team with over 25 years of combined experience in the field of breathomics, cloud applications, IoT solutions and AI. It is our strong conviction that with our multi-disciplinary team and carefully selected technology partners we can bring exhaled breath analysis from a research setting to the patient.
Maurik van den Heuvel
Chief Executive OfficerMaurik van den Heuvel has professional experience in Artificial Intelligence and data science & analytics. He has a degree in economics and is working on a PhD in drug utilization research. His principal areas of expertise are in the pharmaceutical industry, healthcare, FMCG and finance. He has broad international business experience with top tier manufacturing and consulting companies. Maurik brings the experience and the people needed to implement the cutting edge technology that helps make BreathBase scalable, secure and successful.
Rianne de Vries
Chief Operational Officer, Technical Physician
Rianne de Vries studied Technical Medicine with a masters degree in Medical Signaling. She forms the hybrid between classical medicine and advanced technology and is therefore a new professional who has the knowledge, skills and problem-solving mind-set to design and safely apply improved diagnostics and therapeutics. She developed the signal analysis algorithms of the BreathBase Platform that is connected to the SpiroNose and automatically processes and analyzes the sensor signals in order to diagnose and phenotype disease or to predict therapy response.
Scientific Project Manager, PhD
Niloufar Farzan has a background in pharmaceutical sciences and is focusing on precision medicine. She completed her PhD training at the University of Amsterdam at the Department of Respiratory Medicine. Her main focus of interest during her PhD was on precision medicine in childhood asthma. Her extensive knowledge of biology, pathology and underlying mechanisms of various diseases allows her to identify relevant research opportunities from a clinical, research and patient perspective.
Scientific AdviserProf. Peter Sterk, MD, PhD, has a background in clinical respiratory physiology and is focusing on a systems medicine approach to link complex biology to clinical management of disease. He has launched exhaled breath analysis by eNose in various clinical settings during the past decade. His primary interest is phenotyping of chronic airways diseases, in which eNose analysis has been validated for diagnostic purposes and for subclassification of patients. This enables the identification of responders to existing and new treatments (biologicals). In this way he is contributing to the dissemination of Data Driven Medicine at point of care.
Professional AdviserRazvan Furca currently serves as the CEO of Tecknoworks, a worldwide leader in custom software service. He is a highly-driven, customer-focused software developer with a passion for breathing life into big ideas. Razvan grew Tecknoworks from a one man operation into a world-wide brand with offices around the globe. Over the course of his career, Razvan has become known not just as a visionary leader in the world of software development, but also as a trusted partner among firms seeking ways to prepare for the future and do better business using cutting-edge technology.
Rogier van der Hooft
In recent years, Rogier van der Hooft and his team at CbusineZ (part of CZ Health Insurance) have made great efforts to achieve breakthroughs to keep care for the future affordable and available. Not only in the field of eHealth, tools and robotics, but also with initiatives with hospitals and doctors to make expensive medicines affordable again. Rogier has an MBA and is already working for 17 years at CZ Health Insurance. Rogier has recently been appointed the new chairman of the Board of Directors of CbusineZ.
Breathomix has access to all relevant facilities and infrastructure required for their mission. Breathomix has close ties to Tecknoworks Europe (RO), as an information technology partner, and Microsoft Corporate (US) who helps Breathomix with technical, analytical and legal advice and exposure to the market in most countries around the globe. Breathomix works closely with Evalan (NL), a hardware supplier that is able to support Breathomix with the optimization of the SpiroNose. With leading expertise in medicine, data science, IoT, AI and clinical research, the Breathomix team is uniquely positioned to pioneer the use of breathomics driven diagnostics and precision medicine.